We've found
						6,982
						 archived clinical trials in
						Endocrine
					
				We've found
						6,982
						 archived clinical trials in
						Endocrine
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
	
	An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
	
Updated: 3/21/2014
  
  
  	  A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
		Status: Enrolling	
	Updated: 3/21/2014
Click here to add this to my saved trials
		    
			
	Investigating Markers of Energy Metabolism in the CNS and Periphery in Pregnant Women With Varying Degrees of Insulin Resistance
	
		Status: Enrolling	
	
Updated: 4/8/2014
  
  
  Updated: 4/8/2014
	
	Investigating Markers of Energy Metabolism in the CNS and Periphery in Pregnant Women With Varying Degrees of Insulin Resistance
	
		Status: Enrolling	
	
Updated: 4/8/2014
  
  
  	  Updated: 4/8/2014
Click here to add this to my saved trials
		    
			
	Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
	
Updated: 4/9/2014
  
  
  Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
		Status: Enrolling	
	Updated: 4/9/2014
	
	Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
	
Updated: 4/9/2014
  
  
  	  Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
		Status: Enrolling	
	Updated: 4/9/2014
Click here to add this to my saved trials
		    
			
	Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
	
Updated: 4/15/2014
  
  
  Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
		Status: Enrolling	
	Updated: 4/15/2014
	
	Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
	
Updated: 4/15/2014
  
  
  	  Modulation of Insulin Sensitivity by Betaine Upregulation of FGF21
		Status: Enrolling	
	Updated: 4/15/2014
Click here to add this to my saved trials
		    
			
	Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
	
Updated: 5/20/2014
  
  
  Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease (KXK005).
		Status: Enrolling	
	Updated: 5/20/2014
	
	Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
	
Updated: 5/20/2014
  
  
  	  Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease (KXK005).
		Status: Enrolling	
	Updated: 5/20/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
	
	Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria
	
Updated: 7/1/2014
  
  
  	  A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria
		Status: Enrolling	
	Updated: 7/1/2014
Click here to add this to my saved trials
		    
			
	Metabolic Actions of Omega-3 Fatty Acids
	
Updated: 7/2/2014
  
  
  Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
		Status: Enrolling	
	Updated: 7/2/2014
	
	Metabolic Actions of Omega-3 Fatty Acids
	
Updated: 7/2/2014
  
  
  	  Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
		Status: Enrolling	
	Updated: 7/2/2014
Click here to add this to my saved trials
		    
			
	Metabolic Actions of Omega-3 Fatty Acids
	
Updated: 7/2/2014
  
  
  Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
		Status: Enrolling	
	Updated: 7/2/2014
	
	Metabolic Actions of Omega-3 Fatty Acids
	
Updated: 7/2/2014
  
  
  	  Metabolic Actions of Omega-3 Fatty Acids on Inflammation and Adipocyte Lipolysis in the Metabolic Syndrome
		Status: Enrolling	
	Updated: 7/2/2014
Click here to add this to my saved trials